Johnson & Johnson 

JNJ:NYSE

最新 变化/%变化股息收益率交易量平均交易量(10天)
89.80 0.00   0.00%2.95%07.5M

市场数据至少延迟20分钟
前收盘 10/14/2013
 
 
 

Johnson & Johnson的最新新闻标题

No News for Johnson & Johnson
 
 
 
 
 
 
更多申报

最近年度/季度SEC申报

10-K
February 22, 2013
这个报告包含了关于公司商业财务和管理层的详细信息。
10-Q
August 1, 2013
季度报告包含财务声明、管理层讨论以及公司事件罗列(分股、收购等)
 
 
 
公司背景
Johnson & Johnson is a holding company. The Company is engaged in the research and development, manufacture and sale of a broad range of products in the health care field. The business of Johnson & Johnson is conducted by more than 275 operating companies located in 60 countries, including the United States, which sell products in virtually all countries throughout the world. In March 2013, Johnson & Johnson's Cordis Corporation announced the acquisition Of Flexible Stenting Solutions, Inc. In June 2013, Johnson & Johnson announced the opening of the Johnson & Johnson Innovation center in Boston. In August 2013, Johnson & Johnson announced it has completed its acquisition of Aragon Pharmaceuticals, Inc., a pharmaceutical discovery and development company focused on drugs to treat hormonally driven cancers.

买方价/量
-- / --
卖方价/量
-- / --
开盘价格
0.00
前收盘价格
89.80
当天最高
0.00
当天最低
0.00
52周高/日期
94.42 / 7/31/2013
52周低/日期
68.07 / 10/15/2012
与52周高变化%
-4.89%
与52周低变化%
31.92%
贝他(5年)
0.6
市值
253.1B
流通股数
2.8B
波动平均(Volatility Avg)
12.48
每股收益(EPS)(TTM)
4.50
市盈率(P/E)
20.0
股息宣布日
7/15/2013
股息收益率
2.95%
除息日
8/23/2013
登记日
8/27/2013
支付数额
0.66 - 每季
支付日期
9/10/2013
上次交易10/14/2013 4:02 PM ET
 
 
 

JNJ Johnson & Johnson 对比同行

同行 
JNJ
Johnson & Johnson
28.10%
General Electric Company
16.15%
The Procter & Gamble Company
15.98%
Pfizer Inc.
17.03%
JNJ
Johnson & Johnson
2.94%
General Electric Company
3.12%
The Procter & Gamble Company
3.06%
Pfizer Inc.
3.27%
JNJ
Johnson & Johnson
0.00%
General Electric Company
0.00%
The Procter & Gamble Company
0.00%
Pfizer Inc.
0.00%
比较这些股票